Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutations
| author | |
| created | [InstanceEdit:9699313] Rothfels, Karen, 2020-09-14 |
| dbId | 9699314 |
| displayName | Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutations |
| journal | Blood Adv |
| pages | 514-524 |
| pubMedIdentifier | 32040554 |
| schemaClass | LiteratureReference |
| title | Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutations |
| url | http://www.ncbi.nlm.nih.gov/pubmed/32040554 |
| volume | 4 |
| year | 2020 |
Referrals
© 2026 Reactome
